Clinical Trial Update: A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) [Phase 1]

View source ↗

Summary

Phase 1 trial update for a CD19-targeted CAR T cell therapy in pediatric patients with relapsed or refractory B cell acute lymphoblastic leukemia and relapsed o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: Autolus Limited | Conditions: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia, Relapsed or Refractory B Cell Non-Hodgkin Lymphoma | Phase 1 | Status: RECRUITING